+987.9%
MRNA vs SPMO
+11.0%
+977.0%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | SPMO | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | -0.8% | +14.0% | +13.3% |
| 7D | +20.6% | -8.9% | +29.5% | +23.4% |
| 30D | +27.1% | -13.8% | +40.9% | +31.0% |
| 3M | +353.4% | -12.5% | +365.9% | +366.3% |
| 6M | +446.3% | -1.5% | +447.7% | +380.7% |
| YTD | +776.2% | +11.3% | +764.8% | +581.5% |
| 1Y | +987.9% | +11.5% | +976.5% | +742.6% |
| All | +987.9% | +11.0% | +977.0% | +742.6% |
Cumulative growth
Daily Returns
Daily percentage return beside SPMO.
Daily Out/Under-Performance
Portfolio return minus SPMO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SPMO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded SPMO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling